Literature DB >> 20546343

Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma.

Mathias Voigt1, Dagmar-Christiane Fischer, Max Rimpau, Wolfgang Schareck, Dieter Haffner.   

Abstract

AIMS: Human atheroma calcification occurs secondary to repetitive injury/remodelling of the vessel wall and might be initiated by adherence of mineral-loaded fetuin-A whether or not professional matrix mineralizing cells are present. The aim was to investigate the contribution of fibroblast growth factor (FGF)-23 to ectopic mineralization. METHODS AND
RESULTS: Serial sections of formalin-fixed paraffin-embedded human carotid atheroma (n = 54) were investigated with respect to (i) size and distribution of calcific deposits, (ii) indicators of chondrogenic/osteogenic transformation, and (iii) expression of fetuin-A and FGF-23. All specimens were calcified and SOX-9, collagen type II, cathepsin-K, fetuin-A and FGF-23 expression was seen in 46, 53, 53, 54 and 48 specimens, respectively. The intracellular detection of FGF-23 (45/48) indicates local synthesis. Whereas fetuin-A expression was seen also within areas of vascular smooth muscle actin-positive cells adjacent to calcific deposits, FGF-23 expression was apparently restricted to the mineralization-prone areas. Both local expression and FGF-23 serum concentrations were significantly associated with the degree of atheroma calcification.
CONCLUSIONS: Besides the induction of bone islets and subsequent mineral deposition, severe remodelling of the vessel wall is sufficient to create a mineralizable fetuin-A-attracting microenvironment. FGF-23 might contribute to the formation of proper mineral, i.e. control local phosphate concentration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546343     DOI: 10.1111/j.1365-2559.2010.03547.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

Review 1.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

2.  FGF23 protein expression in coronary arteries is associated with impaired kidney function.

Authors:  Natalie A van Venrooij; Renata C Pereira; Yin Tintut; Michael C Fishbein; Navdeep Tumber; Linda L Demer; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Nephrol Dial Transplant       Date:  2014-01-23       Impact factor: 5.992

Review 3.  The role of fetuin-A in mineral trafficking and deposition.

Authors:  Michael M X Cai; Edward R Smith; Stephen G Holt
Journal:  Bonekey Rep       Date:  2015-05-06

Review 4.  Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

Review 5.  Extrarenal effects of FGF23.

Authors:  Dieter Haffner; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2016-10-04       Impact factor: 3.714

6.  Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.

Authors:  Nirav H Shah; Chuanhui Dong; Mitchell S V Elkind; Ralph L Sacco; Armando J Mendez; Barry I Hudson; Shonni Silverberg; Myles Wolf; Tatjana Rundek; Clinton B Wright
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-25       Impact factor: 8.311

7.  Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.

Authors:  Clinton B Wright; Nirav H Shah; Armando J Mendez; Janet T DeRosa; Mitsuhiro Yoshita; Mitchell S V Elkind; Ralph L Sacco; Charles DeCarli; Tatjana Rundek; Shonni Silverberg; Chuanhui Dong; Myles Wolf
Journal:  Stroke       Date:  2016-03-08       Impact factor: 7.914

8.  Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.

Authors:  Yifu Fang; Charles Ginsberg; Toshifumi Sugatani; Marie-Claude Monier-Faugere; Hartmut Malluche; Keith A Hruska
Journal:  Kidney Int       Date:  2013-07-24       Impact factor: 10.612

9.  A protective role for FGF-23 in local defence against disrupted arterial wall integrity?

Authors:  Dongxing Zhu; Neil C W Mackenzie; Jose Luis Millan; Colin Farquharson; Vicky E MacRae
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

Review 10.  Paracrine Effects of FGF23 on the Heart.

Authors:  Maren Leifheit-Nestler; Dieter Haffner
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.